Report cover image

Global Women's Health Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 206 Pages
SKU # APRC20360983

Description

Summary

According to APO Research, The global Women's Health market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Women's Health is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Women's Health is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Women's Health is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Women's Health is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Women's Health include Ferring, Foundation Consumer Healthcare, Hisamitsu, Insud Pharma, Merck & Co, Merck KGaA, Organon Pharma, Theramex and Viatris, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Women's Health, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Women's Health, also provides the sales of main regions and countries. Of the upcoming market potential for Women's Health, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Women's Health sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Women's Health market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Women's Health sales, projected growth trends, production technology, application and end-user industry.

Women's Health Segment by Company

Ferring
Foundation Consumer Healthcare
Hisamitsu
Insud Pharma
Merck & Co
Merck KGaA
Organon Pharma
Theramex
Viatris
AbbVie
Amgen
Bayer
Pfizer
Eli Lilly
Livzon Pharmaceuticals
Qianjin Pharmaceuticals
Teva
Xianjun Pharmaceuticals
Abbott
Zizhu Pharmaceuticals
Women's Health Segment by Type

Hormone Therapy
Nonhormonal Therapy
Women's Health Segment by Application

Postmenopausal Osteoporosis
Climacteric
Infertility
Contraceptive Pill
Others
Women's Health Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Women's Health market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Women's Health and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Women's Health.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Women's Health in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Women's Health manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Women's Health sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Table of Contents

206 Pages
1 Market Overview
1.1 Product Definition
1.2 Women's Health Market by Type
1.2.1 Global Women's Health Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Hormone Therapy
1.2.3 Nonhormonal Therapy
1.3 Women's Health Market by Application
1.3.1 Global Women's Health Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Postmenopausal Osteoporosis
1.3.3 Climacteric
1.3.4 Infertility
1.3.5 Contraceptive Pill
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Women's Health Market Dynamics
2.1 Women's Health Industry Trends
2.2 Women's Health Industry Drivers
2.3 Women's Health Industry Opportunities and Challenges
2.4 Women's Health Industry Restraints
3 Global Market Growth Prospects
3.1 Global Women's Health Revenue Estimates and Forecasts (2020-2031)
3.2 Global Women's Health Revenue by Region
3.2.1 Global Women's Health Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Women's Health Revenue by Region (2020-2025)
3.2.3 Global Women's Health Revenue by Region (2026-2031)
3.2.4 Global Women's Health Revenue Market Share by Region (2020-2031)
3.3 Global Women's Health Sales Estimates and Forecasts 2020-2031
3.4 Global Women's Health Sales by Region
3.4.1 Global Women's Health Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Women's Health Sales by Region (2020-2025)
3.4.3 Global Women's Health Sales by Region (2026-2031)
3.4.4 Global Women's Health Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Women's Health Revenue by Manufacturers
4.1.1 Global Women's Health Revenue by Manufacturers (2020-2025)
4.1.2 Global Women's Health Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Women's Health Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Women's Health Sales by Manufacturers
4.2.1 Global Women's Health Sales by Manufacturers (2020-2025)
4.2.2 Global Women's Health Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Women's Health Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Women's Health Sales Price by Manufacturers (2020-2025)
4.4 Global Women's Health Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Women's Health Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Women's Health Manufacturers, Product Type & Application
4.7 Global Women's Health Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Women's Health Market CR5 and HHI
4.8.2 2024 Women's Health Tier 1, Tier 2, and Tier 3
5 Women's Health Market by Type
5.1 Global Women's Health Revenue by Type
5.1.1 Global Women's Health Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Women's Health Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Women's Health Revenue Market Share by Type (2020-2031)
5.2 Global Women's Health Sales by Type
5.2.1 Global Women's Health Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Women's Health Sales by Type (2020-2031) & (K Units)
5.2.3 Global Women's Health Sales Market Share by Type (2020-2031)
5.3 Global Women's Health Price by Type
6 Women's Health Market by Application
6.1 Global Women's Health Revenue by Application
6.1.1 Global Women's Health Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Women's Health Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Women's Health Revenue Market Share by Application (2020-2031)
6.2 Global Women's Health Sales by Application
6.2.1 Global Women's Health Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Women's Health Sales by Application (2020-2031) & (K Units)
6.2.3 Global Women's Health Sales Market Share by Application (2020-2031)
6.3 Global Women's Health Price by Application
7 Company Profiles
7.1 Ferring
7.1.1 Ferring Comapny Information
7.1.2 Ferring Business Overview
7.1.3 Ferring Women's Health Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Ferring Women's Health Product Portfolio
7.1.5 Ferring Recent Developments
7.2 Foundation Consumer Healthcare
7.2.1 Foundation Consumer Healthcare Comapny Information
7.2.2 Foundation Consumer Healthcare Business Overview
7.2.3 Foundation Consumer Healthcare Women's Health Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Foundation Consumer Healthcare Women's Health Product Portfolio
7.2.5 Foundation Consumer Healthcare Recent Developments
7.3 Hisamitsu
7.3.1 Hisamitsu Comapny Information
7.3.2 Hisamitsu Business Overview
7.3.3 Hisamitsu Women's Health Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Hisamitsu Women's Health Product Portfolio
7.3.5 Hisamitsu Recent Developments
7.4 Insud Pharma
7.4.1 Insud Pharma Comapny Information
7.4.2 Insud Pharma Business Overview
7.4.3 Insud Pharma Women's Health Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Insud Pharma Women's Health Product Portfolio
7.4.5 Insud Pharma Recent Developments
7.5 Merck & Co
7.5.1 Merck & Co Comapny Information
7.5.2 Merck & Co Business Overview
7.5.3 Merck & Co Women's Health Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Merck & Co Women's Health Product Portfolio
7.5.5 Merck & Co Recent Developments
7.6 Merck KGaA
7.6.1 Merck KGaA Comapny Information
7.6.2 Merck KGaA Business Overview
7.6.3 Merck KGaA Women's Health Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Merck KGaA Women's Health Product Portfolio
7.6.5 Merck KGaA Recent Developments
7.7 Organon Pharma
7.7.1 Organon Pharma Comapny Information
7.7.2 Organon Pharma Business Overview
7.7.3 Organon Pharma Women's Health Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Organon Pharma Women's Health Product Portfolio
7.7.5 Organon Pharma Recent Developments
7.8 Theramex
7.8.1 Theramex Comapny Information
7.8.2 Theramex Business Overview
7.8.3 Theramex Women's Health Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Theramex Women's Health Product Portfolio
7.8.5 Theramex Recent Developments
7.9 Viatris
7.9.1 Viatris Comapny Information
7.9.2 Viatris Business Overview
7.9.3 Viatris Women's Health Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Viatris Women's Health Product Portfolio
7.9.5 Viatris Recent Developments
7.10 AbbVie
7.10.1 AbbVie Comapny Information
7.10.2 AbbVie Business Overview
7.10.3 AbbVie Women's Health Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 AbbVie Women's Health Product Portfolio
7.10.5 AbbVie Recent Developments
7.11 Amgen
7.11.1 Amgen Comapny Information
7.11.2 Amgen Business Overview
7.11.3 Amgen Women's Health Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Amgen Women's Health Product Portfolio
7.11.5 Amgen Recent Developments
7.12 Bayer
7.12.1 Bayer Comapny Information
7.12.2 Bayer Business Overview
7.12.3 Bayer Women's Health Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Bayer Women's Health Product Portfolio
7.12.5 Bayer Recent Developments
7.13 Pfizer
7.13.1 Pfizer Comapny Information
7.13.2 Pfizer Business Overview
7.13.3 Pfizer Women's Health Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Pfizer Women's Health Product Portfolio
7.13.5 Pfizer Recent Developments
7.14 Eli Lilly
7.14.1 Eli Lilly Comapny Information
7.14.2 Eli Lilly Business Overview
7.14.3 Eli Lilly Women's Health Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Eli Lilly Women's Health Product Portfolio
7.14.5 Eli Lilly Recent Developments
7.15 Livzon Pharmaceuticals
7.15.1 Livzon Pharmaceuticals Comapny Information
7.15.2 Livzon Pharmaceuticals Business Overview
7.15.3 Livzon Pharmaceuticals Women's Health Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Livzon Pharmaceuticals Women's Health Product Portfolio
7.15.5 Livzon Pharmaceuticals Recent Developments
7.16 Qianjin Pharmaceuticals
7.16.1 Qianjin Pharmaceuticals Comapny Information
7.16.2 Qianjin Pharmaceuticals Business Overview
7.16.3 Qianjin Pharmaceuticals Women's Health Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Qianjin Pharmaceuticals Women's Health Product Portfolio
7.16.5 Qianjin Pharmaceuticals Recent Developments
7.17 Teva
7.17.1 Teva Comapny Information
7.17.2 Teva Business Overview
7.17.3 Teva Women's Health Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 Teva Women's Health Product Portfolio
7.17.5 Teva Recent Developments
7.18 Xianjun Pharmaceuticals
7.18.1 Xianjun Pharmaceuticals Comapny Information
7.18.2 Xianjun Pharmaceuticals Business Overview
7.18.3 Xianjun Pharmaceuticals Women's Health Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 Xianjun Pharmaceuticals Women's Health Product Portfolio
7.18.5 Xianjun Pharmaceuticals Recent Developments
7.19 Abbott
7.19.1 Abbott Comapny Information
7.19.2 Abbott Business Overview
7.19.3 Abbott Women's Health Sales, Revenue, Price and Gross Margin (2020-2025)
7.19.4 Abbott Women's Health Product Portfolio
7.19.5 Abbott Recent Developments
7.20 Zizhu Pharmaceuticals
7.20.1 Zizhu Pharmaceuticals Comapny Information
7.20.2 Zizhu Pharmaceuticals Business Overview
7.20.3 Zizhu Pharmaceuticals Women's Health Sales, Revenue, Price and Gross Margin (2020-2025)
7.20.4 Zizhu Pharmaceuticals Women's Health Product Portfolio
7.20.5 Zizhu Pharmaceuticals Recent Developments
8 North America
8.1 North America Women's Health Market Size by Type
8.1.1 North America Women's Health Revenue by Type (2020-2031)
8.1.2 North America Women's Health Sales by Type (2020-2031)
8.1.3 North America Women's Health Price by Type (2020-2031)
8.2 North America Women's Health Market Size by Application
8.2.1 North America Women's Health Revenue by Application (2020-2031)
8.2.2 North America Women's Health Sales by Application (2020-2031)
8.2.3 North America Women's Health Price by Application (2020-2031)
8.3 North America Women's Health Market Size by Country
8.3.1 North America Women's Health Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Women's Health Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Women's Health Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Women's Health Market Size by Type
9.1.1 Europe Women's Health Revenue by Type (2020-2031)
9.1.2 Europe Women's Health Sales by Type (2020-2031)
9.1.3 Europe Women's Health Price by Type (2020-2031)
9.2 Europe Women's Health Market Size by Application
9.2.1 Europe Women's Health Revenue by Application (2020-2031)
9.2.2 Europe Women's Health Sales by Application (2020-2031)
9.2.3 Europe Women's Health Price by Application (2020-2031)
9.3 Europe Women's Health Market Size by Country
9.3.1 Europe Women's Health Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Women's Health Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Women's Health Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Netherlands
9.3.9 Nordic Countries
10 China
10.1 China Women's Health Market Size by Type
10.1.1 China Women's Health Revenue by Type (2020-2031)
10.1.2 China Women's Health Sales by Type (2020-2031)
10.1.3 China Women's Health Price by Type (2020-2031)
10.2 China Women's Health Market Size by Application
10.2.1 China Women's Health Revenue by Application (2020-2031)
10.2.2 China Women's Health Sales by Application (2020-2031)
10.2.3 China Women's Health Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Women's Health Market Size by Type
11.1.1 Asia Women's Health Revenue by Type (2020-2031)
11.1.2 Asia Women's Health Sales by Type (2020-2031)
11.1.3 Asia Women's Health Price by Type (2020-2031)
11.2 Asia Women's Health Market Size by Application
11.2.1 Asia Women's Health Revenue by Application (2020-2031)
11.2.2 Asia Women's Health Sales by Application (2020-2031)
11.2.3 Asia Women's Health Price by Application (2020-2031)
11.3 Asia Women's Health Market Size by Country
11.3.1 Asia Women's Health Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Women's Health Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Women's Health Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Women's Health Market Size by Type
12.1.1 SAMEA Women's Health Revenue by Type (2020-2031)
12.1.2 SAMEA Women's Health Sales by Type (2020-2031)
12.1.3 SAMEA Women's Health Price by Type (2020-2031)
12.2 SAMEA Women's Health Market Size by Application
12.2.1 SAMEA Women's Health Revenue by Application (2020-2031)
12.2.2 SAMEA Women's Health Sales by Application (2020-2031)
12.2.3 SAMEA Women's Health Price by Application (2020-2031)
12.3 SAMEA Women's Health Market Size by Country
12.3.1 SAMEA Women's Health Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Women's Health Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Women's Health Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Women's Health Value Chain Analysis
13.1.1 Women's Health Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Women's Health Production Mode & Process
13.2 Women's Health Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Women's Health Distributors
13.2.3 Women's Health Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.